Pharmaceutical Supply & Distribution (Ipratropium Bromide)

The contract seeks the supply and delivery of Ipratropium Bromide identified by NSN 6505-01-391-6109, adhering strictly to DLA medical packaging, labeling, and shipping standards to ensure compliance with federal healthcare logistics requirements. The product must be furnished in accordance with all applicable regulatory and procedural guidelines for pharmaceutical items distributed through the Department of Defense supply chain, including proper documentation, sterility, and tamper-evident packaging. The place of performance is designated as San Diego, CA, with the contract falling under the NAICS code 325412 for pharmaceutical and medicinal chemical manufacturing. This is a subcontract opportunity, with responses due by May 18, 2026, and the solicitation was posted on May 13, 2026, under the Medical Supply Chain Pharm FSA. Participation requires full alignment with DLA’s specifications for military medical inventory control, traceability, and end-to-end distribution integrity.